Literature DB >> 16758372

Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.

Leonel Daza1, Martin Aguirre, Martin Jimenez, Rafael Herrera, J J Bollain.   

Abstract

High atherosclerosis prevalence was found in rheumatoid arthritis (RA), and the von Willebrand factor (vWF) was shown to be a marker for endothelial damage. The aim of this study was to evaluate the association of intima-media thickness of the left common carotid artery with vWF serum levels in rheumatoid arthritis patients without cardiovascular risk factors. We included 55 RA female patients, each with at least 5 years of duration of the disease, and 20 healthy female subjects as members of the control group. The vWF, cholesterol, triglycerides, and the immune variables-rheumatoid factor and reactive C protein-were evaluated. The media thickness and intima-media thickness (IMT) in patients and in the control subjects were assessed by Doppler ultrasound of the left common carotid artery. Although the ages for RA patients and healthy female controls were not different, the IMT of the left common carotid artery (IMT CCA) in rheumatoid arthritis patients was increased in comparison with healthy control measurements, the mean being 0.67 mm (SD 0.18) vs 0.58 mm (SD 0.10) with a p value 0.01. The vWF serum levels showed differences in RA patients from those in control patients, 145.6 (SD 30.08) vs 121.8 (SD 37.17), respectively, with p=0.007. A correlation was also found between vWF with IMT CCA in the RA patients: r=0.390 and p<0.05. We concluded that the measurements of the left common carotid artery intima-media thickness together with the von Willebrand factor serum levels could give valuable information about the artery status and the atherosclerosis process in early stages in patients with rheumatoid arthritis without cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758372     DOI: 10.1007/s10067-006-0338-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  30 in total

1.  Hemostatic factors and cardiovascular disease in active rheumatoid arthritis: an 8 year followup study.

Authors:  S Wållberg-Jonsson; M Cederfelt; S Rantapää Dahlqvist
Journal:  J Rheumatol       Date:  2000-01       Impact factor: 4.666

2.  Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.

Authors:  P A Klimiuk; S Sierakowski; R Latosiewicz; J P Cylwik; B Cylwik; J Skowronski; J Chwiecko
Journal:  Clin Exp Rheumatol       Date:  2003 Jan-Feb       Impact factor: 4.473

3.  Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries.

Authors:  A Srámek; J G Bosch; J H Reiber; J A Van Oostayen; F R Rosendaal
Journal:  Invest Radiol       Date:  2000-12       Impact factor: 6.016

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

5.  Estimating the incidence of rheumatoid arthritis: trying to hit a moving target?

Authors:  N Wiles; D P Symmons; B Harrison; E Barrett; J H Barrett; D G Scott; A J Silman
Journal:  Arthritis Rheum       Date:  1999-07

6.  Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate.

Authors:  M Hoekstra; C J Haagsma; C J A Doelman; M A F J van de Laar
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

7.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors.

Authors:  I D del Rincón; K Williams; M P Stern; G L Freeman; A Escalante
Journal:  Arthritis Rheum       Date:  2001-12

8.  Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound.

Authors:  Yong-Beom Park; Chul-Woo Ahn; Hyon K Choi; Seung-Hoon Lee; Byung-Hyun In; Hyun-Chul Lee; Chung-Mo Nam; Soo-Kon Lee
Journal:  Arthritis Rheum       Date:  2002-07

9.  Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects.

Authors:  Inmaculada Del Rincón; Ken Williams; Michael P Stern; Gregory L Freeman; Daniel H O'Leary; Agustín Escalante
Journal:  Arthritis Rheum       Date:  2003-07

10.  Low fasting serum triglyceride level as a precocious marker of autoimmune disorders.

Authors:  Silvia Iannello; Antonina Cavaleri; Paolina Milazzo; Santi Cantarella; Francesco Belfiore
Journal:  MedGenMed       Date:  2003-08-07
View more
  16 in total

1.  Prothrombotic markers in asymptomatic dyslipidemic subjects.

Authors:  David Karasek; Helena Vaverkova; Milan Halenka; Dagmar Jackuliakova; Zdenek Frysak; Ludek Slavik; Dalibor Novotny
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

Review 2.  Validated methods for assessment of subclinical atherosclerosis in rheumatology.

Authors:  György Kerekes; Pál Soltész; Michael T Nurmohamed; Miguel A Gonzalez-Gay; Maurizio Turiel; Edit Végh; Yehuda Shoenfeld; Iain McInnes; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2012-02-21       Impact factor: 20.543

Review 3.  Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians.

Authors:  Kai-Hang Yiu; Hung-Fat Tse; Mo-Yin Mok; Chak-Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2011-09-13       Impact factor: 20.543

4.  Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis?

Authors:  Tolga Kurt; Ahmet Temiz; Ferhat Gokmen; Gurhan Adam; Sedat Ozcan; Ersan Ozbudak; Mustafa Sacar
Journal:  Wien Klin Wochenschr       Date:  2015-03-17       Impact factor: 1.704

Review 5.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 6.  Rheumatoid arthritis and cardiovascular disease.

Authors:  Mary Chester M Wasko
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

7.  Carotid enlargement and serum levels of von Willebrand factor in rheumatoid arthritis: a follow-up study.

Authors:  Mirjana Veselinovic; Vladimir Jakovljevic; Aleksandra Jurisic-Skevin; Slavco Toncev; Dragan M Djuric
Journal:  Clin Rheumatol       Date:  2012-09-09       Impact factor: 2.980

Review 8.  Statin treatment for rheumatoid arthritis: a promising novel indication.

Authors:  Kosmas I Paraskevas
Journal:  Clin Rheumatol       Date:  2007-12-08       Impact factor: 2.980

9.  Do carotid artery diameters manifest early evidence of atherosclerosis in women with rheumatoid arthritis?

Authors:  Laura L Schott; Amy H Kao; Amy Cunningham; Rachel P Wildman; Lewis H Kuller; Kim Sutton-Tyrrell; Mary Chester M Wasko
Journal:  J Womens Health (Larchmt)       Date:  2009 Jan-Feb       Impact factor: 2.681

Review 10.  Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases.

Authors:  Theodoros Dimitroulas; Aamer Sandoo; George D Kitas
Journal:  Int J Mol Sci       Date:  2012-09-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.